Previous close | 0.7236 |
Open | 0.7236 |
Bid | 0.7510 x 100 |
Ask | 0.7650 x 100 |
Day's range | 0.7025 - 0.7900 |
52-week range | 0.5000 - 4.4800 |
Volume | |
Avg. volume | 584,100 |
Market cap | 42.967M |
Beta (5Y monthly) | 0.73 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Cara (CARA) delivered earnings and revenue surprises of -47.37% and 5.11%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
As you might know, Cara Therapeutics, Inc. ( NASDAQ:CARA ) last week released its latest full-year, and things did not...
Cara Therapeutics ( NASDAQ:CARA ) Full Year 2023 Results Key Financial Results Revenue: US$21.0m (down 50% from FY...